Research Article
Management and Outcome in 32 Neonates with Thrombotic Events
Table 1
Baseline and clinical characteristics of 32 neonates with neonatal thrombosis.
| | Treatment group () | βWait-and-seeβ group () | Total () |
| Female gender, n (%) | 15 (60) | 4 (57) | 19 (59) | Gestational age (weeks)* | 30 (27β38) | 28 (25β36) | 29 (27β38) | β<32, n | 15 | 5 | 20 | β, n | 2 | 1 | 3 | β>37, n | 8 | 1 | 9 | Birthweight (g)* | 1256 (817β3300) | 938 (734β2735) | 1145 (789β3230) | β<1000, n | 8 | 4 | 12 | β, n | 6 | 1 | 7 | β>1500, n | 11 | 2 | 13 | UC, n (%) | 18/23 (78) | 5 (71) | 23/30 (77) | PICC, n (%) | 14/22 (64) | 4 (86) | 16/30 (53) | Either UC or PICC, n (%) | 22/23 (96) | 7 (100) | 29/30 (97) | Platelet transfusionsa (%) | 11/21 (52) | 2 (29) | 13/26 (50) |
|
|
*Data presented as median (interquartile range (IQR)).
aDuring total hospital stay.
|